Skip to main content
Livermore
Livermore
ZHEN

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding ImmunityBio, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of IBRX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1944182−8
Shares61.9M11.4M68.7M+18.3M (+36.3%)
Value$391.1M$72.4M$255.6M−$63.1M (−19.8%)

4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held ImmunityBio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to IBRX in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.11,857,531$44.1M0.00%
D. E. Shaw & Co., Inc.520,053$1.93M0.00%
ExodusPoint Capital Management, LP135,029$502.0K0.01%
Sherbrooke Park Advisers LLC75,078$279.3K0.06%
Advantage Alpha Capital Partners LP69,207$257.4K0.06%
Intech Investment Management LLC68,140$253.5K0.00%
SG Americas Securities, LLC59,775$222.0K0.00%
Winning Points Advisors, LLC89,396$143.0K0.27%
Quantbot Technologies LP38,412$142.9K0.01%
HighTower Advisors, LLC36,612$136.0K0.00%
Virtu Financial LLC13,608$51.0K0.00%
Acadian Asset Management LLC12,432$46.0K0.00%
Captrust Financial Advisors11,073$41.2K0.00%
Public Employees Retirement Association of Colorado5,517$21.0K0.00%
ZRC Wealth Management, LLC1,500$5.58K0.00%
Lindbrook Capital, LLC1,000$3.72K0.00%
Arcadia Investment Management Corp1,000$3.71K0.00%
Clear Street Markets LLC897$3.00K0.00%
Tradewinds Capital Management, LLC500$1.86K0.00%
Sterling Capital Management LLC213$7920.00%
Gould Capital, LLC117$4350.00%
Fortitude Family Office, LLC95$3530.00%
Farther Finance Advisors, LLC1$40.00%
Hemington Wealth Management42$00.00%

Sold out (32)

Institutions that held ImmunityBio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of IBRX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Marex Group plc218,900$1.38M
Cowen and Company, LLC200,000$1.26M
Mirae Asset Securities (USA) Inc.114,939$726.4K
Tudor Investment Corp Et Al101,046$638.6K
Brevan Howard Capital Management LP96,765$611.6K
Bayesian Capital Management, LP82,100$518.9K
Omers Administration Corp70,300$444.3K
HRT Financial LP67,782$428.0K
Toroso Investments, LLC64,255$406.1K
Schonfeld Strategic Advisors LLC34,626$218.8K
Laurion Capital Management LP25,069$158.4K
Allianz Asset Management GmbH25,000$158.0K
J. Safra Sarasin Holding AG25,000$158.0K
Kapitalo Investimentos Ltda20,170$127.5K
Simplicity Wealth,LLC15,806$99.9K
Aigen Investment Management, LP14,841$93.8K
Gotham Asset Management, LLC14,594$92.2K
Algert Global LLC13,560$85.7K
Alpine Global Management, LLC12,734$80.5K
Legacy Advisors, LLC12,500$79.0K
HSBC Holdings PLC11,545$73.8K
Ameriprise Financial Inc11,155$70.5K
Walleye Capital LLC10,522$66.5K
Meridian Management Co10,000$63.2K
Jefferies Financial Group Inc.7,500$47.4K
Pacer Advisors, Inc.2,478$15.7K
GAMMA Investing LLC1,540$9.73K
West Oak Capital, LLC1,500$9.48K
PSI Advisors, LLC350$2.21K
Toth Financial Advisory Corp150$948
Thurston, Springer, Miller, Herd & Titak, Inc.100$632
Central Bank & Trust Co80$505

Not filed for Q3 2024 yet (4)

Institutions that held ImmunityBio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.11,423,089$72.2M
Susquehanna Fundamental Investments, LLC23,185$146.5K
Institutional & Family Asset Management, LLC3,000$19.0K
Benjamin F. Edwards & Company, Inc.500$3.00K